MODERNA INC (MRNA)       174.615  -1.73 (-0.98%)

174.615  -1.73 (-0.98%)

US60770K1079 - Common Stock

MODERNA INC174.615

NASDAQ:MRNA (2/3/2023, 12:48:08 PM)-1.73 (-0.98%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS Sector Health Care
GICS Industry Biotechnology

Chartmill FA Rating
Valuation Growth
Profitability Health
Dividend

Overview
Earnings (Last) 11-03 2022-11-03/bmo Earnings (Next) 02-22 2023-02-22
Ins Owners 5.42% Inst Owners 63.95%
Market Cap 67.08B Shares 384.18M
PE 6.32 Fwd PE 32.52
Dividend Yield N/A Analysts 74.62
IPO 12-07 2018-12-07

Stock Screener Links

Screen Image

Nasdaq Stock Screener

Find more stocks on Nasdaq

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

MRNA Daily chart

Company Profile

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid (mRNA). The company is headquartered in Cambridge, Massachusetts and currently employs 2,700 full-time employees. The company went IPO on 2018-12-07. The Company’s mRNA medicines are designed to direct the body’s cells to produce intracellular, membrane, or secreted proteins that have a therapeutic or preventive benefit with the potential to address a range of spectrum of diseases. The company is developing vaccines and therapeutics for infectious diseases, immuno-oncology, rare diseases, autoimmune and cardiovascular diseases, independently and with its strategic collaborators. The firm develops technologies that enable the development of mRNA medicines for diverse applications. The company has created modalities, including prophylactic vaccines, systemic secreted and cell surface therapeutics, cancer vaccines, intratumoral immuno-oncology, and systemic intracellular therapeutics. The firm develops technologies that enable the development of mRNA medicines.

Company Info

MODERNA INC

200 Technology Sq

Cambridge MASSACHUSETTS 02139

P: 16177146500.0

CEO: Stephane Bancel

Employees: 2700

Website: https://www.modernatx.com/

MRNA News

News Image3 minutes ago - The Motley Fool3 No-Brainer Growth Stocks to Buy in 2023

These stocks all fell by double digits last year.

News Image5 hours ago - Personalis, Inc.Personalis and Moderna Sign New Agreement to Leverage NeXT Platform™ in Personalized mRNA Cancer Vaccine Clinical TrialsNews Image6 hours ago - The Motley FoolIs Moderna Stock a Buy Now?

The company is starting the year on a strong note.

News Imagea day ago - InvestorPlaceThe 7 Most Undervalued Biotech Stocks to Buy in February 2023

Get your hands on the latest medical innovations at a compelling discount with the most undervalued biotech stocks to buy.

News Imagea day ago - Market News VideoMRNA March 24th Options Begin TradingNews Image2 days ago - InvestorPlaceThe 7 Most Undervalued Nasdaq Stocks to Buy in February 2023

For those seeking the best discounts in the tech-centered index, these are the most undervalued Nasdaq stocks to buy.

MRNA Twits

Here you can normally see the latest stock twits on MRNA, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example